← Leaderboards
Zenan L Chang
University Of California Los Angeles
$134,413
Attributed
$134,413
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $48.6K · FY2014–16$50K$37.5K$25K$12.5K$0
'14
'15
'16
Funding mix
By agency
NIH$134,413 · 1
By mechanism
F30$134,413 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Alexander Hoffmann$30,043,948
- Dennis J McGinty$3,098,457
- Jay R. Lieberman$6,899,796
- James S. Economou$9,911,213
- Sanjiv S Gambhir$44,452,033
Others in their field
Top investigators on “Deoxyuridine”
- Jayanta Chaudhuri · Sloan-Kettering Inst Can Research$6,788,550
- Michio Hirano · Columbia University Health Sciences$5,334,541
- Kenneth Schultz · Trethera Corporation$3,652,876
- Ronald Glaser · Ohio State University$3,316,552
- Gary K Owens · University Of Virginia$3,155,829
- Amin I Kassis · Harvard University (Medical School)$3,052,292
Research focus
DeoxyuridineBaseAntibodiesAngiostatinsCancer TherapyCandidate Disease GeneCell Cycle ArrestCell Mediated Lymphocytolysis TestCell NucleusCell PhysiologyCell ProliferationCellsCellular EngineeringCoculture TechniquesColon Cancer Cell LineConventional TherapyCoupledCytokineCytolysisCytotoxicityCytotoxic T-LymphocytesDefense MechanismsDensityDisease Remission
Grant awards (3)
Engineering robust adoptive T-cell cancer therapy by rewiring TGF-beta signaling$48,576
F30 · FY2016 · CA · contact PI
Engineering robust adoptive T-cell cancer therapy by rewiring TGF-beta signaling$48,120
F30 · FY2015 · CA · contact PI
Engineering robust adoptive T-cell cancer therapy by rewiring TGF-beta signaling$37,717
F30 · FY2014 · CA · contact PI